Arcturus Therapeutics Holdings Inc (ARCT)
17.82
-0.18
(-1.00%)
USD |
NASDAQ |
Nov 04, 16:00
17.83
+0.01
(+0.06%)
After-Hours: 20:00
Arcturus Therapeutics Holdings Enterprise Value: 221.56M for Nov. 4, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 04, 2024 | 221.56M |
| November 01, 2024 | 226.43M |
| October 31, 2024 | 219.13M |
| October 30, 2024 | 236.98M |
| October 29, 2024 | 256.72M |
| October 28, 2024 | 268.89M |
| October 25, 2024 | 252.12M |
| October 24, 2024 | 253.47M |
| October 23, 2024 | 280.52M |
| October 22, 2024 | 274.84M |
| October 21, 2024 | 304.31M |
| October 18, 2024 | 311.61M |
| October 17, 2024 | 296.74M |
| October 16, 2024 | 297.55M |
| October 15, 2024 | 306.75M |
| October 14, 2024 | 305.39M |
| October 11, 2024 | 320.00M |
| October 10, 2024 | 297.01M |
| October 09, 2024 | 331.62M |
| October 08, 2024 | 347.31M |
| October 07, 2024 | 385.17M |
| October 04, 2024 | 385.44M |
| October 03, 2024 | 409.24M |
| October 02, 2024 | 428.71M |
| October 01, 2024 | 422.49M |
| Date | Value |
|---|---|
| September 30, 2024 | 367.32M |
| September 27, 2024 | 335.41M |
| September 26, 2024 | 328.38M |
| September 25, 2024 | 315.94M |
| September 24, 2024 | 327.57M |
| September 23, 2024 | 311.61M |
| September 20, 2024 | 297.01M |
| September 19, 2024 | 308.10M |
| September 18, 2024 | 295.39M |
| September 17, 2024 | 307.83M |
| September 16, 2024 | 297.01M |
| September 13, 2024 | 300.80M |
| September 12, 2024 | 278.08M |
| September 11, 2024 | 307.02M |
| September 10, 2024 | 274.02M |
| September 09, 2024 | 253.47M |
| September 06, 2024 | 245.09M |
| September 05, 2024 | 248.61M |
| September 04, 2024 | 255.10M |
| September 03, 2024 | 264.02M |
| August 30, 2024 | 310.26M |
| August 29, 2024 | 305.66M |
| August 28, 2024 | 303.23M |
| August 27, 2024 | 297.28M |
| August 26, 2024 | 319.46M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
59.67M
Minimum
Mar 22 2023
2.771B
Maximum
Dec 22 2020
526.38M
Average
417.83M
Median
Sep 19 2023
Enterprise Value Benchmarks
| Fulcrum Therapeutics Inc | -70.35M |
| Bioventus Inc | 1.282B |
| Semler Scientific Inc | 200.37M |
| Liquidia Corp | 749.50M |
| Pfizer Inc | 219.16B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -17.22M |
| Revenue (Quarterly) | 45.98M |
| Total Expenses (Quarterly) | 67.10M |
| EPS Diluted (Quarterly) | -0.64 |
| Profit Margin (Quarterly) | -37.45% |
| Earnings Yield | -14.42% |
| Normalized Earnings Yield | -14.32 |